Will pharma sales forces drop (overall) by another 20% in the coming years? ZS Associates thinks yes. Interesting perspectives in this article. FDA missing yet another drug review deadline (Takeda's …
Today’s Top Three in Pharma 011309
FDA approves sharing unapproved drug uses with doctors. "The public health may be advanced by healthcare professionals' receipt of medical journal articles ... on unapproved new uses," the agency …
Pharma News this week
More job cuts coming up at Sanofi U.S. - Chris Viehbacher, the new CEO of Sanofi-Aventis, isn’t a man to let the grass grow under his feet. Just two days in his new job, and Sanofi is cutting its U.S. …
Pharma News this week
Glaxo: more big cuts, and the U.S. HQ needle pointing south - GlaxoSmithKline (GSK) announced that it will reduce its sales personnel by 12% to 7,500 down from 8,500. The company will slash 1,800 jobs …
Pharma News this week
Sanofi-Aventis suspends sale of Acomplia in Europe. Acomplia, an obesity drug that once looked like it would be a blockbuster for Sanofi-Aventis, is being pulled off the market in Europe. The EMEA, …
Pharma News 10_20
Novartis to cut a bunch more (sales) jobs; does another management shuffle - As reorganizations go, this one reaches most parts of the company. First, the drugmaker is cutting 550 sales reps, although …